10-K · February 20, 2026
CoreCivic presents evidence of near-term demand tailwinds from federal policy and appropriations (notably the Laken Riley Act and the OBBBA appropriation) that drove activations of idle facilities and higher occupancy…
Earnings analysis · 10-Q
CXW earnings analysis
Filed May 7, 2026 · Our reading of the company's report
The latest report
CoreCivic's Q1 2026 results demonstrated significant growth, outperforming revenue and EPS expectations with revenues of $614.7 million and diluted EPS of $0.38. The company benefitted from increased demand from federal…
Read full summary
CoreCivic's Q1 2026 results demonstrated significant growth, outperforming revenue and EPS expectations with revenues of $614.7 million and diluted EPS of $0.38. The company benefitted from increased demand from federal contracts, particularly in relation to ICE, resulting in expanded operations and increased average compensated population.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $0.38
- Operating margin
- 24.0%
- Segment
- CoreCivic Safety
- Segment
- CoreCivic Community
- Segment
- CoreCivic Properties
What stood out
-
Q1 Revenue Surged
Total revenue for Q1 2026 reached $614.7 million, a 25.8% increase from $488.6 million in Q1 2025.
-
EPS Beat Estimates
Reported diluted EPS was $0.38, significantly up from $0.23 in Q1 2025, marking a 65.2% increase.
-
Strong Federal Revenue Growth
Federal management revenue increased 48.4% to $358.1 million, reflecting higher occupancy rates.
-
Positive Operating Margin Improvement
Operating margin improved to 24.0% in Q1 2026, compared to 23.6% in Q1 2025.
-
CoreCivic Safety Segment Growth
CoreCivic Safety revenue rose by 27.2% to $577.9 million, driven by increased operational capacity.
-
Acquisition Contributes to Growth
The acquisition of Clinical Solutions Pharmacy is expected to diversify cash flows and enhance operational capabilities.
What to watch
-
Increased Operating Expenses
Operating expenses increased by 25.2% to $467.7 million amid heightened staffing costs and new facility activations.
-
Dependence on Federal Contracts
Reliance on federal contracts poses a risk if demand decreases due to changes in immigration policy or government funding.
-
Litigation Risks Related to Facilities
Ongoing litigation at the California City Facility may affect operational capacity and financial performance.
Management's outlook
Management anticipates continued demand growth from ICE and additional federal contracts may further improve operational capacity.
Earlier filings 4
10-Q · May 8, 2025
CoreCivic reported quarterly revenue of $488,627,000 (three months ended March 31, 2025) versus $500,686,000 a year ago, a decline of $12,059,000. Net income improved to $25,113,000 (diluted EPS $0.23) from $9,543,000…
10-Q · August 8, 2024
CoreCivic reported Q2 revenue of $490,109,000 (up from $463,682,000 in Q2 2023) and diluted EPS of $0.17 (up from $0.13). Operating income improved to $48,319,000 (operating margin ~9.9%) and cash flow from operations…
10-Q · May 9, 2024
CoreCivic reported Q1 revenue of $500,686,000 (up $42,684,000, +9.3% vs. Q1 2023) with operating income roughly $54,388,000 (operating margin ~10.9%, up ~220 bps y/y). Net income was $9,543,000 (diluted EPS $0.08)…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.